Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery

Recruiting now

Conditions studied: Scoliosis; Spinal Fusion; Blood Transfusion; Operative Blood Loss

In brief

Spine surgery for scoliosis correction in pediatric patients is a major procedure associated with a high risk of perioperative blood loss. Homologous blood transfusion carries inherent risks, including immunological reactions, infections, and increased healthcare costs. Identifying high-risk patients is crucial to optimize blood conservation strategies. This retrospective study aims to identify preoperative and intraoperative risk factors associated with homologous red blood cell (RBC) transfusion and to evaluate the quantitative impact of Cell Saver volume reinfusion on reducing homologous transfusion requirements.

Key facts

Study ID

NCT07661589

Run by

Mehdi Trifa

People needed

200

Starts

2023-04-01

Expected to finish

2026-12-31

Last updated by the study team

2026-06-22

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient aged under 18 years (< 18 years old).
• Programmed surgical correction for scoliosis (including idiopathic, neuromuscular, and congenital etiologies).
• Instrumented surgery involving posterior spinal arthrodesis.

You may not qualify if…

• Revision spine surgeries.
• Known constitutional hemostasis disorders.
• Non-orthopedic spine surgeries.
• Missing core clinical or transfusion data.

Where it is running

• Bechir Hamza Children Hospital — Tunis, Tunisia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.